Shapira C (Hard Medical school, Boston MA, USA), Cook N, Evans D, Willett W, Fajardo I, Koch-Eser D, Bergonzoli G. Bolanos O, R, uerrero and Charles H Hennekens C H. A case-control study of BCG and children tuberculosis in Cali, Colombia. Istituto Malattie Infettive, Università di Roma ‘La Sapienza’ Reprint requests to: Dr Claudio Galli, via Giuseppe Valmarana 107, 00139 Roma, Italy. We conducted a case-control study to evaluate the effectiveness of BCG vaccination in preventing childhood tuberculosis (TB) in Cali, Colombia. We ascertained 178 cases aged 0 to 14 years from the respiratory clinics with cough or fever for at least three weeks and a positive chest X-ray for TB, as well as 320 controls who were from the same house-holds but had no symptoms and negative X-rays. Using matched set multiple logistic regression analysis, we found the age- and sex-adjusted relative risk (RR) of TB among vaccinees compared with non-vaccinees to be 0.84 with 95% confidence limits (CL) from 0.43 to 1.62. There was, however, a significantly lowered relative risk of TB with increasing time since vaccination (RR = 0.83 per year since time of vaccination with 95% CL from 0.74 to 0.94.)
No takes yet. Share an insight, caveat, or question.
Shapiro et al. (1985) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: